Incidence of pulmonary complications with the prophylactic use of high-flow nasal cannula after pediatric cardiac surgery: Prophylactic HFNC study protocol

Naohiro Shioji; Tomoyuki Kanazawa; Tatsuo Iwasaki; Kazuyoshi Shimizu; Tomohiko Suemori; Hirokazu Kawase; Satoshi Kimura; Yasutoshi Kuroe; Hiroshi Morimatsu

Incidence of pulmonary complications with the prophylactic use of high-flow nasal cannula after pediatric cardiac surgery: Prophylactic HFNC study protocol

Naohiro Shioji, Tomoyuki Kanazawa, Tatsuo Iwasaki, Kazuyoshi Shimizu, Tomohiko Suemori, Hirokazu Kawase, Satoshi Kimura, Yasutoshi Kuroe, Hiroshi Morimatsu

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

We will investigate the incidence of postoperative pulmonary complications (PPCs) with the prophylactic use of a high-flow nasal cannula (HFNC) after pediatric cardiac surgery. Children < 48 months old with congenital heart disease for whom cardiac surgery is planned will be included. The HFNC procedure will be commenced just after extubation, at a flow rate of 2 L/kg/min with adequate oxygen concentration to achieve target oxygen saturation ≥ 94%. This study will reveal the prevalence of PPCs after pediatric cardiac surgery with the prophylactic use of HFNC.

Original language	English
Pages (from-to)	193-196
Number of pages	4
Journal	Acta medica Okayama
Volume	72
Issue number	2
Publication status	Published - 2018

Keywords

Congenital heart disease
High-flow nasal cannula
Pediatric cardiac surgery
Postoperative pulmonary complications

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{e62ad54360264a6684f92a0fb22d2119,

title = "Incidence of pulmonary complications with the prophylactic use of high-flow nasal cannula after pediatric cardiac surgery: Prophylactic HFNC study protocol",

abstract = "We will investigate the incidence of postoperative pulmonary complications (PPCs) with the prophylactic use of a high-flow nasal cannula (HFNC) after pediatric cardiac surgery. Children < 48 months old with congenital heart disease for whom cardiac surgery is planned will be included. The HFNC procedure will be commenced just after extubation, at a flow rate of 2 L/kg/min with adequate oxygen concentration to achieve target oxygen saturation ≥ 94%. This study will reveal the prevalence of PPCs after pediatric cardiac surgery with the prophylactic use of HFNC.",

keywords = "Congenital heart disease, High-flow nasal cannula, Pediatric cardiac surgery, Postoperative pulmonary complications",

author = "Naohiro Shioji and Tomoyuki Kanazawa and Tatsuo Iwasaki and Kazuyoshi Shimizu and Tomohiko Suemori and Hirokazu Kawase and Satoshi Kimura and Yasutoshi Kuroe and Hiroshi Morimatsu",

note = "Funding Information: We thank Professor Shiro Hinotsu at the Center for the Innovative Clinical Medicine in Okayama University Hospital for his assistance with the protocol design. Publisher Copyright: {\textcopyright} 2018 by Okayama University Medical School.",

year = "2018",

language = "English",

volume = "72",

pages = "193--196",

journal = "Acta Medica Okayama",

issn = "0386-300X",

publisher = "Okayama University",

number = "2",

}

TY - JOUR

T1 - Incidence of pulmonary complications with the prophylactic use of high-flow nasal cannula after pediatric cardiac surgery

T2 - Prophylactic HFNC study protocol

AU - Shioji, Naohiro

AU - Kanazawa, Tomoyuki

AU - Iwasaki, Tatsuo

AU - Shimizu, Kazuyoshi

AU - Suemori, Tomohiko

AU - Kawase, Hirokazu

AU - Kimura, Satoshi

AU - Kuroe, Yasutoshi

AU - Morimatsu, Hiroshi

N1 - Funding Information: We thank Professor Shiro Hinotsu at the Center for the Innovative Clinical Medicine in Okayama University Hospital for his assistance with the protocol design. Publisher Copyright: © 2018 by Okayama University Medical School.

PY - 2018

Y1 - 2018

N2 - We will investigate the incidence of postoperative pulmonary complications (PPCs) with the prophylactic use of a high-flow nasal cannula (HFNC) after pediatric cardiac surgery. Children < 48 months old with congenital heart disease for whom cardiac surgery is planned will be included. The HFNC procedure will be commenced just after extubation, at a flow rate of 2 L/kg/min with adequate oxygen concentration to achieve target oxygen saturation ≥ 94%. This study will reveal the prevalence of PPCs after pediatric cardiac surgery with the prophylactic use of HFNC.

AB - We will investigate the incidence of postoperative pulmonary complications (PPCs) with the prophylactic use of a high-flow nasal cannula (HFNC) after pediatric cardiac surgery. Children < 48 months old with congenital heart disease for whom cardiac surgery is planned will be included. The HFNC procedure will be commenced just after extubation, at a flow rate of 2 L/kg/min with adequate oxygen concentration to achieve target oxygen saturation ≥ 94%. This study will reveal the prevalence of PPCs after pediatric cardiac surgery with the prophylactic use of HFNC.

KW - Congenital heart disease

KW - High-flow nasal cannula

KW - Pediatric cardiac surgery

KW - Postoperative pulmonary complications

UR - http://www.scopus.com/inward/record.url?scp=85047203519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047203519&partnerID=8YFLogxK

M3 - Article

C2 - 29674770

AN - SCOPUS:85047203519

SN - 0386-300X

VL - 72

SP - 193

EP - 196

JO - Acta Medica Okayama

JF - Acta Medica Okayama

IS - 2

ER -

Incidence of pulmonary complications with the prophylactic use of high-flow nasal cannula after pediatric cardiac surgery: Prophylactic HFNC study protocol

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this